Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONACO: Corifollitropin Alfa vs Modified Natural Cycles in Poor Responders
NCT04487925Phase 4Recruiting
- Sponsor
- Ghent University Hospital
- Start
- Jan 2022
- Primary completion
- Sep 2024
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of corifollitropin alfa in female infertility, sponsored by Ghent University Hospital. Started Jan 2022; status: recruiting.
02
Drugs
corifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT04487925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487925.